Biocon Biologics

Biocon Biologics is a medical company that develops biosimilars. It offers spanning recombinant human Insulin (rh-Insulin), insulin analogs, monoclonal antibodies, and other recombinant proteins for the treatment of diabetes, cancer, autoimmune conditions, and other life-threatening diseases.

TypeSubsidiary
Parent CompanyBiocon
Founded1978
Biocon Biologics was founded in 1978

Viewing summary data as a guest

Sign up for free to see all data

Biocon Biologics Financials and Metrics

Summary Metrics

Founding Date

1978

Total Funding

$255.2 m

Investors

In total, Biocon Biologics had raised $255.2 m. Biocon Biologics is a subsidiary of Biocon

Biocon Biologics Online and Social Media Presence

Embed Graph

Biocon Biologics News and Updates

[Funding alert] Biocon Biologics raises Rs 555Cr from Abu Dhabi-based ADR at $4.17B valuation

The funding announcement comes two months after Biocon Biologics raised funds from Goldman Sachs. It will deploy the raised funds to expand its capabilities

[Funding alert] Biocon Biologics gets Rs 1,125 Cr capital infusion from Goldman Sachs

Capital injection of Rs 1,125 Cr by Goldman Sachs will enable Biocon Biologics to invest in R&D, high-quality manufacturing, and establish a global commercial footprint.

Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes

HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India, Aug. 31, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Biocon Biologics India Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today announced the U.S. launch of Semglee™ (insulin glargine injection) in vial...

Biocon Biologics valued at $3.5 billion after Tata Capital's $30 million financing

Tata Capital will invest Rs 225 crore or $30 million for 0.85% stake in Biocon's biosimilar business Biocon Biologics, valuing the company at $3.5 billion, Biocon said on Friday. The transaction is subject to standard condition precedents and approvals. Post the completion of this transaction, Bioco…

Biocon Biologics Frequently Asked Questions

  • When was Biocon Biologics founded?

    Biocon Biologics was founded in 1978.

  • How many employees does Biocon Biologics have?

    Biocon Biologics has 1,286 employees.

  • Who are Biocon Biologics competitors?

    Competitors of Biocon Biologics include Balmes Transplantation, BioFactura and CF PharmTech.